PCR and Real-time PCR Molecular Diagnostics Market

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Market Analysis and Forecast, 2023-2033

5. Market Outlook

    5.1. Technology Advancement

    5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)

    5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global Market Value Forecast, by Technology

    6.1. Introduction and Definition

    6.2. Global Market Value Forecast, by Technology, 2023-2033

        6.2.1. Traditional PCR

        6.2.2. Real-time PCR

        6.2.3. Digital PCR

    6.3. Global Market Attractiveness Analysis, by Technology

7. Global Market Value (US$ Mn) Forecast, by Product

    7.1. Introduction and Definition

    7.2. Global Market Value Forecast, by Technology, 2023-2033

        7.2.1. Instruments

        7.2.2. Reagents

        7.2.3. Consumables

    7.3. Global Market Attractiveness Analysis, by Product

8. Global Market Value (US$ Mn) Forecast, by Application

    8.1. Introduction and Definition

    8.2. Global Market Value Forecast, by Technology, 2023-2033

        8.2.1. Infectious Diseases Testing

            8.2.1.1. HCV and HBV

            8.2.1.2. Sexually Transmitted Infections

            8.2.1.3. Hospital Acquired Infection

            8.2.1.4. Respiratory Infections

            8.2.1.5. Others

        8.2.2. Oncology Testing

        8.2.3. Genetic Testing

        8.2.4. Others

    8.3. Global Market Attractiveness Analysis, by Application

9. Global Market Value (US$ Mn) Forecast, by End-user

    9.1. Introduction and Definition

    9.2. Global Market Value Forecast, by End-user, 2023-2033

        9.2.1. Hospitals

        9.2.2. Diagnostic Laboratories

        9.2.3. Academic and Research Centers

        9.2.4. Others

    9.3. Global Market Attractiveness Analysis, by End-user

10. Global Market Value (US$ Mn) Forecast, by Region

    10.1. Introduction

    10.2. Global Market Value Forecast, by Region, 2023-2033

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East and Africa

    10.3. Global Market Attractiveness Analysis, by Region

11. North America Market Analysis and Forecast

    11.1. Introduction

    11.2. North America Market Value Forecast, by Technology, 2023-2033

        11.2.1. Traditional PCR

        11.2.2. Real-time PCR

        11.2.3. Digital PCR

    11.3. North America Market Value Forecast, by Product, 2023-2033

        11.3.1. Instruments

        11.3.2. Reagents

        11.3.3. Consumables

    11.4. North America Market Value Forecast, by Application, 2023-2033

        11.4.1. Infectious Diseases Testing

            11.4.1.1. HCV and HBV

            11.4.1.2. Sexually Transmitted Infections

            11.4.1.3. Hospital Acquired Infection

            11.4.1.4. Respiratory Infections

            11.4.1.5. Others

        11.4.2. Oncology Testing

        11.4.3. Genetic Testing

        11.4.4. Others

    11.5. North America Market Value Forecast, by End-user, 2023-2033

        11.5.1. Hospitals

        11.5.2. Diagnostic Laboratories

        11.5.3. Academic and Research Centers

    11.6. North America Market Value Forecast, by Country, 2023-2033

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Market Attractiveness Analysis

        11.7.1. By Technology

        11.7.2. By Product

        11.7.3. By Application

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Market Analysis and Forecast

    12.1. Introduction

    12.2. Europe Market Value Forecast, by Technology, 2023-2033

        12.2.1. Traditional PCR

        12.2.2. Real-time PCR

        12.2.3. Digital PCR

    12.3. Europe Market Value Forecast, by Product, 2023-2033

        12.3.1. Instruments

        12.3.2. Reagents

        12.3.3. Consumables

    12.4. Europe Market Value Forecast, by Application, 2023-2033

        12.4.1. Infectious Diseases Testing

            12.4.1.1. HCV and HBV

            12.4.1.2. Sexually Transmitted Infections

            12.4.1.3. Hospital Acquired Infection

            12.4.1.4. Respiratory Infections

            12.4.1.5. Others

        12.4.2. Oncology Testing

        12.4.3. Genetic Testing

        12.4.4. Others

    12.5. Europe Market Value Forecast, by End-user, 2023-2033

        12.5.1. Hospitals

        12.5.2. Diagnostic Laboratories

        12.5.3. Academic and Research Centers

    12.6. Europe Market Value Forecast, by Country/Sub-region, 2023-2033

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Market Attractiveness Analysis

        12.7.1. By Technology

        12.7.2. By Product

        12.7.3. By Application

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Market Analysis and Forecast

    13.1. Introduction

    13.2. Asia Pacific Market Value Forecast, by Technology, 2023-2033

        13.2.1. Traditional PCR

        13.2.2. Real-time PCR

        13.2.3. Digital PCR

    13.3. Asia Pacific Market Value Forecast, by Product, 2023-2033

        13.3.1. Instruments

        13.3.2. Reagents

        13.3.3. Consumables

    13.4. Asia Pacific Market Value Forecast, by Application, 2023-2033

        13.4.1. Infectious Diseases Testing

            13.4.1.1. HCV and HBV

            13.4.1.2. Sexually Transmitted Infections

            13.4.1.3. Hospital Acquired Infection

            13.4.1.4. Respiratory Infections

            13.4.1.5. Others

        13.4.2. Oncology Testing

        13.4.3. Genetic Testing

        13.4.4. Others

    13.5. Asia Pacific Market Value Forecast, by End-user, 2023-2033

        13.5.1. Hospitals

        13.5.2. Diagnostic Laboratories

        13.5.3. Academic and Research Centers

    13.6. Asia Pacific Market Value Forecast, by Country/Sub-region, 2023-2033

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia and New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Market Attractiveness Analysis

        13.7.1. By Technology

        13.7.2. By Product

        13.7.3. By Application

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Market Analysis and Forecast

    14.1. Introduction

    14.2. Latin America Market Value Forecast, by Technology, 2023-2033

        14.2.1. Traditional PCR

        14.2.2. Real-time PCR

        14.2.3. Digital PCR

    14.3. Latin America Market Value Forecast, by Product, 2023-2033

        14.3.1. Instruments

        14.3.2. Reagents

        14.3.3. Consumables

    14.4. Latin America Market Value Forecast, by Application, 2023-2033

        14.4.1. Infectious Diseases Testing

            14.4.1.1. HCV and HBV

            14.4.1.2. Sexually Transmitted Infections

            14.4.1.3. Hospital Acquired Infection

            14.4.1.4. Respiratory Infections

            14.4.1.5. Others

        14.4.2. Oncology Testing

        14.4.3. Genetic Testing

        14.4.4. Others

    14.5. Latin America Market Value Forecast, by End-user, 2023-2033

        14.5.1. Hospitals

        14.5.2. Diagnostic Laboratories

        14.5.3. Academic and Research Centers

    14.6. Latin America Market Value Forecast, by Country/Sub-region, 2023-2033

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Market Attractiveness Analysis

        14.7.1. By Technology

        14.7.2. By Product

        14.7.3. By Application

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East and Africa Market Analysis and Forecast

    15.1. Introduction

    15.2. Middle East and Africa Market Value Forecast, by Technology, 2023-2033

        15.2.1. Traditional PCR

        15.2.2. Real-time PCR

        15.2.3. Digital PCR

    15.3. Middle East and Africa Market Value Forecast, by Product, 2023-2033

        15.3.1. Instruments

        15.3.2. Reagents

        15.3.3. Consumables

    15.4. Middle East and Africa Market Value Forecast, by Application, 2023-2033

        15.4.1. Infectious Diseases Testing

            15.4.1.1. HCV and HBV

            15.4.1.2. Sexually Transmitted Infections

            15.4.1.3. Hospital Acquired Infection

            15.4.1.4. Respiratory Infections

            15.4.1.5. Others

        15.4.2. Oncology Testing

        15.4.3. Genetic Testing

        15.4.4. Others

    15.5. Middle East and Africa Market Value Forecast, by End-user, 2023-2033

        15.5.1. Hospitals

        15.5.2. Diagnostic Laboratories

        15.5.3. Academic and Research Centers

    15.6. Middle East and Africa Market Value Forecast, by Country/Sub-region, 2023-2033

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East and Africa

    15.7. Middle East and Africa Market Attractiveness Analysis

        15.7.1. By Technology

        15.7.2. By Product

        15.7.3. By Application

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Global Market Position Analysis, by Company, 2020

    16.3. Company Profiles

        16.3.1. Abbott Laboratories

            16.3.1.1. Company Description

            16.3.1.2. Business Overview

            16.3.1.3. Financial Overview

            16.3.1.4. Strategic Overview

            16.3.1.5. SWOT Analysis

        16.3.2. Elekta AB Bio-Rad Laboratories, Inc.

            16.3.2.1. Company Description

            16.3.2.2. Business Overview

            16.3.2.3. Financial Overview

            16.3.2.4. Strategic Overview

            16.3.2.5. SWOT Analysis

        16.3.3. bioMérieux SA

            16.3.3.1. Company Description

            16.3.3.2. Business Overview

            16.3.3.3. Financial Overview

            16.3.3.4. Strategic Overview

            16.3.3.5. SWOT Analysis

        16.3.4. Danaher Corporation

            16.3.4.1. Company Description

            16.3.4.2. Business Overview

            16.3.4.3. Financial Overview

            16.3.4.4. Strategic Overview

            16.3.4.5. SWOT Analysis

        16.3.5. Thermo Fisher Scientific, Inc.

            16.3.5.1. Company Description

            16.3.5.2. Business Overview

            16.3.5.3. Financial Overview

            16.3.5.4. Strategic Overview

            16.3.5.5. SWOT Analysis

        16.3.6. Becton, Dickinson and Company

            16.3.6.1. Company Description

            16.3.6.2. Business Overview

            16.3.6.3. Financial Overview

            16.3.6.4. Strategic Overview

            16.3.6.5. SWOT Analysis

        16.3.7. F. Hoffmann-La Roche Ltd

            16.3.7.1. Company Description

            16.3.7.2. Business Overview

            16.3.7.3. Financial Overview

            16.3.7.4. Strategic Overview

            16.3.7.5. SWOT Analysis

        16.3.8. QIAGEN N.V.

            16.3.8.1. Company Description

            16.3.8.2. Business Overview

            16.3.8.3. Financial Overview

            16.3.8.4. Strategic Overview

            16.3.8.5. SWOT Analysis

        16.3.9. Hologic, Inc.

            16.3.9.1. Company Description

            16.3.9.2. Business Overview

            16.3.9.3. Financial Overview

            16.3.9.4. Strategic Overview

            16.3.9.5. SWOT Analysis

        16.3.10. GRIFOLS, S.A.

            16.3.10.1. Company Description

            16.3.10.2. Business Overview

            16.3.10.3. Financial Overview

            16.3.10.4. Strategic Overview

            16.3.10.5. SWOT Analysis

        16.3.11. Genomic Health

            16.3.11.1. Company Description

            16.3.11.2. Business Overview

            16.3.11.3. Financial Overview

            16.3.11.4. Strategic Overview

            16.3.11.5. SWOT Analysis

        16.3.12. Seegene, Inc.

            16.3.12.1. Company Description

            16.3.12.2. Business Overview

            16.3.12.3. Financial Overview

            16.3.12.4. Strategic Overview

            16.3.12.5. SWOT Analysis

17. Research Methodology

18. Acronyms and Assumptions Used

List Of Table

Table 01: Global In-vitro Diagnostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2023-2033

Table 02: Global Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 03: Global Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 04: Global Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 05: Global Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 07: Global Market Value (US$ Mn) Forecast, by Region, 2023-2033

Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023-2033

Table 09: North America Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 10: North America Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 11: North America Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 12: North America Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 13: North America Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 14: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 15: Europe Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 16: Europe Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 17: Europe Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 18: Europe Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 19: Europe Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 25: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 26: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 27: Latin America Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 28: Latin America Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 29: Latin America Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 30: Latin America Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 31: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023-2033

Table 32: Middle East and Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033

Table 33: Middle East and Africa Market Value (US$ Mn) Forecast, by Technology, 2023-2033

Table 34: Middle East and Africa Market Value (US$ Mn) Forecast, by Product, 2023-2033

Table 35: Middle East and Africa Market Value (US$ Mn) Forecast, by Application, 2023-2033

Table 36: Middle East and Africa Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033

Table 37: Middle East and Africa Market Value (US$ Mn) Forecast, by End-user, 2023-2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Share Specifics with Me

List Of Figures

Figure 01: Global Market Value (US$ Mn) Forecast, 2023-2033

Figure 02: Global Market Value Share, by Technology, 2020

Figure 03: Global Market Value Share, by Product, 2020

Figure 04: Global Market Value Share, by Application, 2020

Figure 05: Global Market Value Share, by End-user, 2020

Figure 06: Global Market Value Share Analysis, by Technology, 2023 and 2033

Figure 07: Global Market Attractiveness Analysis, by Technology, 2023–2033

Figure 08: Global Market Value (US$ Mn), by Traditional PCR, 2023-2033

Figure 09: Global Market Value (US$ Mn), by Real-time PCR, 2023-2033

Figure 10: Global Market Value (US$ Mn), by Digital PCR, 2023-2033

Figure 11: Global Market Value Share Analysis, by Product, 2023 and 2033

Figure 12: Global Market Attractiveness Analysis, by Product, 2023–2033

Figure 13: Global Market Value (US$ Mn), by Instruments, 2023-2033

Figure 14: Global Market Value (US$ Mn), by Reagents, 2023-2033

Figure 15: Global Market Value (US$ Mn), by Consumables, 2023-2033

Figure 16: Global Market Value Share Analysis, by Application, 2023 and 2033

Figure 17: Global Market Attractiveness Analysis, by Application, 2023–2033

Figure 18: Global Market Value (US$ Mn), by Infectious Diseases, 2023-2033

Figure 19: Global Market Value (US$ Mn), by Oncology, 2023-2033

Figure 20: Global Market Value (US$ Mn), by Genetic Testing, 2023-2033

Figure 21: Global Market Value Share Analysis, by Others, 2023 and 2033

Figure 22: Global Market Value Share Analysis, by End-user, 2023 and 2033

Figure 23: Global Market Attractiveness Analysis, by End-user 2023–2033

Figure 24: Global Market Value (US$ Mn), by Hospitals 2023-2033

Figure 25: Global Market Value (US$ Mn), by Diagnostic Laboratories, 2023-2033

Figure 26: Global Market Value (US$ Mn), by Academic and Research Institutes, 2023-2033

Figure 27: Global Market Value (US$ Mn), by Others, 2023-2033

Figure 28: Global Market Value Share Analysis, by Region, 2023 and 2033

Figure 29: Global Market Attractiveness Analysis, by Region, 2023–2033

Figure 30: North America PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033

Figure 31: North America Market Value Share Analysis, by Country, 2023 and 2033

Figure 32: North America Market Attractiveness Analysis, by Country, 2023–2033

Figure 33: North America Market Value Share Analysis, by Technology, 2023 and 2033

Figure 34: North America Market Attractiveness Analysis, by Technology, 2023–2033

Figure 35: North America Market Value Share Analysis, by Product, 2023 and 2033

Figure 36: North America Market Attractiveness Analysis, by Product, 2023–2033

Figure 37: North America Market Value Share Analysis, by Application, 2023 and 2033

Figure 38: North America Market Attractiveness Analysis, by Application, 2023–2033

Figure 39: North America Market Value Share Analysis, by End-user, 2023 and 2033

Figure 40: North America Market Attractiveness Analysis, by End-user, 2023–2033

Figure 41: Europe PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033

Figure 42: Europe Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 43: Europe Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 44: Europe Market Value Share Analysis, by Technology, 2023 and 2033

Figure 45: Europe Market Attractiveness Analysis, by Technology, 2023–2033

Figure 46: Europe Market Value Share Analysis, by Product, 2023 and 2033

Figure 47: Europe Market Attractiveness Analysis, by Product, 2023–2033

Figure 48: Europe Market Value Share Analysis, by Application, 2023 and 2033

Figure 49: Europe Market Attractiveness Analysis, by Application, 2023–2033

Figure 50: Europe Market Value Share Analysis, by End-user, 2023 and 2033

Figure 51: Europe Market Attractiveness Analysis, by End-user, 2023–2033

Figure 52: Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033

Figure 53: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 54: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 55: Asia Pacific Market Value Share Analysis, by Technology, 2023 and 2033

Figure 56: Asia Pacific Market Attractiveness Analysis, by Technology, 2023–2033

Figure 57: Asia Pacific Market Value Share Analysis, by Product, 2023 and 2033

Figure 58: Asia Pacific Market Attractiveness Analysis, by Product, 2023–2033

Figure 59: Asia Pacific Market Value Share Analysis, by Application, 2023 and 2033

Figure 60: Asia Pacific Market Attractiveness Analysis, by Application, 2023–2033

Figure 61: Asia Pacific Market Value Share Analysis, by End-user, 2023 and 2033

Figure 62: Asia Pacific Market Attractiveness Analysis, by End-user, 2023–2033

Figure 63: Latin America PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033

Figure 64: Latin America Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 65: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 66: Latin America Market Value Share Analysis, by Technology, 2023 and 2033

Figure 67: Latin America Market Attractiveness Analysis, by Technology, 2023–2033

Figure 68: Latin America Market Value Share Analysis, by Product, 2023 and 2033

Figure 69: Latin America Market Attractiveness Analysis, by Product, 2023–2033

Figure 70: Latin America Market Value Share Analysis, by Application, 2023 and 2033

Figure 71: Latin America Market Attractiveness Analysis, by Application, 2023–2033

Figure 72: Latin America Market Value Share Analysis, by End-user, 2023 and 2033

Figure 73: Latin America Market Attractiveness Analysis, by End-user, 2023–2033

Figure 74: Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033

Figure 75: Middle East and Africa Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 76: Middle East and Africa Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 77: Middle East and Africa Market Value Share Analysis, by Technology, 2023 and 2033

Figure 78: Middle East and Africa Market Attractiveness Analysis, by Technology, 2023–2033

Figure 79: Middle East and Africa Market Value Share Analysis, by Product, 2023 and 2033

Figure 80: Middle East and Africa Market Attractiveness Analysis, by Product, 2023–2033

Figure 81: Middle East and Africa Market Value Share Analysis, by Application, 2023 and 2033

Figure 82: Middle East and Africa Market Attractiveness Analysis, by Application, 2023–2033

Figure 83: Middle East and Africa Market Value Share Analysis, by End-user, 2023 and 2033

Figure 84: Middle East and Africa Market Attractiveness Analysis, by End-user, 2023–2033

Figure 85: Global PCR and Real-time PCR Molecular Diagnostics Market Share Analysis, by Company, 2020